4.7 Letter

Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis

Alexandre R. Marra et al.

Summary: This study assessed the short-term effectiveness of COVID-19 vaccines among immunocompromised patients and found that they were effective against symptomatic COVID-19 infection but had lower effectiveness compared to the control group. Further research is needed to understand the discordance between antibody production and protection against symptomatic COVID-19 infection.

JOURNAL OF INFECTION (2022)

Article Multidisciplinary Sciences

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jeremy Manry et al.

Summary: This study investigates the impact of autoimmunity on COVID-19-related deaths and finds that individuals carrying autoantibodies neutralizing type I interferons are at higher risk of death, with the risk decreasing with age.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Review Virology

The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update

Saade Abdalkareem Jasim et al.

Summary: The interaction between the immune system and SARS-CoV-2 is crucial for understanding COVID-19 pathogenesis and developing therapeutic tools. Different immune components play various roles in viral infections, and characterizing the immune reactions is essential for defining the pathogenicity of COVID-19. Furthermore, investigating the roles of other immune mediators in the immunopathogenesis of COVID-19 is necessary.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Immunology

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4

Fanny Onodi et al.

Summary: Studies have shown that human pDCs can be efficiently activated by SARS-CoV-2 particles and may contribute to type I IFN-dependent immunity against SARS-CoV-2 infection.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Multidisciplinary Sciences

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

Elsa Brunet-Ratnasingham et al.

Summary: This study conducted immunovirological assessments on plasma from 279 individuals to identify early predictors of mortality in patients infected with SARS-CoV-2. High vRNA, low specific immunoglobulin G and antibody-dependent cellular cytotoxicity, and elevated cytokines and tissue injury markers were strongly associated with mortality. A three-variable model combining vRNA, age, and sex was able to robustly identify patients with fatal outcomes.

SCIENCE ADVANCES (2021)

Article Microbiology

Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection

Martina Severa et al.

Summary: The study highlights the crucial role of pDC/type I IFN axis in defending against SARS-CoV-2 infection in COVID-19 patients, suggesting that a deeper understanding may aid in the development of new drug strategies and host-directed therapies. Moreover, the findings indicate that critically ill patients exhibit impaired type I IFN response and high levels of inflammatory cytokines and chemokines, leading to multi-organ failure.

PLOS PATHOGENS (2021)

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)